CE

Cell Bio Human Tech Co., Ltd

318160 | KO

Overview

Corporate Details

ISIN(s):
KR7318160009
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 시민대로 401 대륭테크노타운15차 제2001호,제2101호, 안양시
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 31.8 KB
2025-09-19 00:00
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
Korean 53.0 KB
2025-08-28 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 28.2 KB
2025-08-28 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 28.2 KB
2025-08-28 00:00
Transaction in Own Shares
신탁계약해지결과보고서
Korean 20.6 KB
2025-08-28 00:00
Transaction in Own Shares
신탁계약해지결과보고서
Korean 22.3 KB
2025-08-28 00:00
Transaction in Own Shares
[기재정정]주요사항보고서(자기주식취득신탁계약해지결정)
Korean 31.1 KB
2025-08-28 00:00
Interim / Quarterly Report
[기재정정]반기보고서 (2025.06)
Korean 1.2 MB
2025-08-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-06-02 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-05-27 00:00
Major Shareholding Notification
신탁계약에의한취득상황보고서
Korean 52.6 KB
2025-05-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB

Automate Your Workflow. Get a real-time feed of all Cell Bio Human Tech Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cell Bio Human Tech Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cell Bio Human Tech Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Silexion Therapeutics Corp Logo
Developing a local drug delivery platform to treat KRAS-driven cancers and solid tumors.
United States of America
SLXN
Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.
South Korea
215600
Simris Group AB Logo
Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.
Sweden
SIMRIS
Skye Bioscience, Inc. Logo
Clinical-stage biotech developing a CB1-inhibiting antibody for obesity and metabolic diseases.
United States of America
SKYE
SLSBio(Specialty Lab Solution Bio) Co., Ltd Logo
Provides pharma lab services, clinical trial analysis, and innovative diagnostic products.
South Korea
246250
Soiken Holdings Inc. Logo
A bioscience group offering clinical testing, supplements, and cosmetics for pharma/food industries.
Japan
2385
Solid Biosciences Inc. Logo
Advancing gene therapies and technologies for rare neuromuscular and cardiac diseases.
United States of America
SLDB
SpectraCure Logo
Developing a high-precision, minimally invasive therapy for internal tumors like prostate cancer.
Sweden
SPEC
Sprint Bioscience Logo
Develops & out-licenses preclinical oncology drugs for difficult-to-treat cancers.
Sweden
SPRINT
SPRUCE BIOSCIENCES, INC. Logo
Developing first-in-class therapies for serious, underserved neurological conditions like MPS IIIB.
United States of America
SPRB

Talk to a Data Expert

Have a question? We'll get back to you promptly.